(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
BioXcel Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, November 12th, 2025 | 2023 | Vimal Mehta, Ph.D. Chief Executive Officer | 1,001,569 | 0 | 1,097,600 | 0 | 16,050 | 4,731,147 |
| Wednesday, November 12th, 2025 | 2024 | Javier Rodriguez Senior VP and Chief Legal Officer | 423,833 | 0 | 181,755 | 0 | 8,625 | 1,012,552 |
| Wednesday, November 12th, 2025 | 2023 | Javier Rodriguez Senior VP and Chief Legal Officer | 423,833 | 0 | 191,588 | 0 | 8,250 | 1,121,943 |
| Wednesday, November 12th, 2025 | 2024 | Richard Steinhart SVP and Chief Financial Officer | 409,872 | 0 | 181,755 | 0 | 4,128 | 998,216 |
| Wednesday, November 12th, 2025 | 2024 | Vimal Mehta, Ph.D. Chief Executive Officer | 1,001,570 | 0 | 0 | 0 | 16,425 | 1,119,245 |
| Monday, April 29th, 2024 | 2023 | Vimal Mehta, Ph.D. Chief Executive Officer | 1,001,569 | 0 | 1,097,600 | 0 | 16,050 | 4,731,147 |
| Monday, April 29th, 2024 | 2022 | Matthew Wiley SVP and Chief Commercial Officer | 402,500 | 0 | 0 | 210,000 | 7,625 | 1,927,697 |
| Monday, April 29th, 2024 | 2023 | Matthew Wiley SVP and Chief Commercial Officer | 445,200 | 0 | 250,388 | 0 | 8,250 | 1,264,394 |
| Monday, April 29th, 2024 | 2022 | Javier Rodriguez Senior VP and Chief Legal Officer | 403,650 | 50,000 | 181,439 | 177,606 | 7,625 | 1,218,539 |
| Monday, April 29th, 2024 | 2023 | Javier Rodriguez Senior VP and Chief Legal Officer | 423,833 | 0 | 191,588 | 0 | 8,250 | 1,121,943 |
| Monday, April 29th, 2024 | 2022 | Vimal Mehta, Ph.D. Chief Executive Officer | 944,436 | 150,000 | 800,592 | 654,662 | 15,425 | 4,559,195 |
| Wednesday, May 17th, 2023 | 2021 | Vimal Mehta, Ph.D. Chief Executive Officer | 916,701 | 0 | 0 | 483,052 | 7,800 | 9,372,177 |
| Wednesday, May 17th, 2023 | 2022 | Vimal Mehta, Ph.D. Chief Executive Officer | 944,436 | 150,000 | 800,592 | 654,662 | 15,425 | 4,559,195 |
| Wednesday, May 17th, 2023 | 2022 | Javier Rodriguez Senior VP and Chief Legal Officer | 403,650 | 50,000 | 181,439 | 177,606 | 7,625 | 1,218,539 |
| Wednesday, May 17th, 2023 | 2021 | Javier Rodriguez Senior VP and Chief Legal Officer | 334,028 | 0 | 0 | 136,500 | 0 | 2,014,426 |
| Wednesday, May 17th, 2023 | 2022 | Matthew Wiley | 402,500 | 0 | 0 | 210,000 | 7,625 | 1,927,697 |
| Tuesday, April 5th, 2022 | 2021 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 916,701 | 0 | 0 | 483,052 | 7,800 | 9,372,177 |
| Tuesday, April 5th, 2022 | 2020 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 890,000 | 0 | 0 | 556,250 | 7,800 | 9,576,550 |
| Tuesday, April 5th, 2022 | 2021 | Javier Rodriquez | 334,028 | 0 | 0 | 136,500 | 0 | 2,014,426 |
| Tuesday, April 5th, 2022 | 2021 | Frank Yocca | 333,250 | 0 | 0 | 112,912 | 6,420 | 1,153,469 |
| Tuesday, April 27th, 2021 | 2019 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 459,000 | 0 | 0 | 233,000 | 7,800 | 1,968,931 |
| Tuesday, April 27th, 2021 | 2020 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 890,000 | 0 | 0 | 556,250 | 7,800 | 9,576,550 |
| Tuesday, April 27th, 2021 | 2020 | Reina Benabou, M.D., Ph.D. | 197,443 | 0 | 0 | 76,341 | 0 | 2,736,184 |
| Tuesday, April 27th, 2021 | 2020 | William P. Kane, Jr. | 245,455 | 0 | 0 | 138,699 | 0 | 4,569,654 |
| Monday, April 6th, 2020 | 2019 | Richard Steinhart Chief Financial Officer | 285,600 | 0 | 0 | 114,125 | 4,272 | 403,997 |
| Monday, April 6th, 2020 | 2018 | Vincent O’Neill, M.D. Chief Medical Officer | 336,941 | 65,665 | 0 | 0 | 502 | 663,301 |
| Monday, April 6th, 2020 | 2019 | Vimal Mehta, Ph.D. President and Chief Executive Officer | 459,000 | 0 | 0 | 233,000 | 7,800 | 1,968,931 |
| Monday, April 6th, 2020 | 2019 | Vincent O’Neill, M.D. Chief Medical Officer | 406,167 | 0 | 0 | 102,800 | 1,200 | 510,167 |
| Monday, April 6th, 2020 | 2018 | Vimal Mehta, Ph.D. President and Chief Executive Officer | 423,359 | 270,000 | 0 | 0 | 8,250 | 701,609 |
| Monday, April 1st, 2019 | 2018 | Vincent O'Neill Senior Vice President and Chief | 336,941 | 65,665 | 0 | 0 | 502 | 663,301 |
| Monday, April 1st, 2019 | 2017 | Vincent O'Neill Senior Vice President and Chief | 49,500 | 0 | 0 | 0 | 0 | 90,560 |
| Monday, April 1st, 2019 | 2017 | Vimal Mehta President and Chief Executive | 147,000 | 0 | 0 | 0 | 10,599 | 283,531 |
| Monday, April 1st, 2019 | 2018 | Vimal Mehta President and Chief Executive | 423,359 | 270,000 | 0 | 0 | 8,250 | 701,609 |
| Monday, April 1st, 2019 | 2017 | Frank Yocca, Ph.D. Senior Vice President and Chief | 168,000 | 0 | 0 | 0 | 0 | 209,999 |
| Monday, April 1st, 2019 | 2018 | Frank Yocca, Ph.D. Senior Vice President and Chief | 296,863 | 93,400 | 0 | 0 | 3,250 | 654,408 |
